Hypothalamic insulin and glucagon-like peptide-1 levels in an animal model of depression and their effect on corticotropin-releasing hormone promoter gene activity in a hypothalamic cell line

Pharmacol Rep. 2019 Apr;71(2):338-346. doi: 10.1016/j.pharep.2018.11.001. Epub 2018 Nov 27.

Abstract

Background: In depression, excessive glucocorticoid action may cause maladaptive brain changes, including in the pathways controlling energy metabolism. Insulin and glucagon-like peptide-1 (GLP-1), besides regulation of glucose homeostasis, also possess neurotrophic properties. Current study was aimed at investigating the influence of prenatal stress (PS) on insulin, GLP-1 and their receptor (IR and GLP-1R) levels in the hypothalamus. GLP-1 and GLP-1R were assayed also in the hippocampus and frontal cortex - brain regions mainly affected in depression. The second objective was to determine the influence of exendin-4 and insulin on CRH promoter gene activity in in vitro conditions.

Methods: Adult male PS rats were subjected to acute stress and/or received orally glucose. Levels of hormones and their receptors were assayed with ELISA method. In vitro studies were performed on mHypoA-2/12 hypothalamic cell line, stably transfected with CRH promoter coupled with luciferase.

Results: PS has reduced GLP-1 and GLP-1R levels, attenuated glucose-induced increase in insulin concentration and increased the amount of phosphorylated IR in the hypothalamus of animals subjected to additional stress stimuli, and also decreased the GLP-1R level in the hippocampus. In vitro studies demonstrated that insulin is capable of increasing CRH promoter activity in the condition of stimulation of the cAMP/PKA pathway in the applied cellular model.

Conclusion: Prenatal stress may act as a preconditioning factor, affecting the concentrations of hormones such as insulin and GLP-1 in the hypothalamus in response to adverse stimuli. The decreased GLP-1R level in the hippocampus could be linked with the disturbances in neuronal plasticity.

Keywords: Corticotropin-releasing hormone; Depression; Glucagon-like peptide-1; Hypothalamus; Insulin; mHypoA-2/12.

MeSH terms

  • Animals
  • Cell Line
  • Corticotropin-Releasing Hormone / genetics
  • Depression / physiopathology*
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Exenatide / metabolism
  • Female
  • Glucagon-Like Peptide 1 / metabolism*
  • Glucose / metabolism
  • Hypothalamus / metabolism*
  • Insulin / metabolism*
  • Male
  • Mice
  • Neuronal Plasticity / physiology
  • Pregnancy
  • Prenatal Exposure Delayed Effects / physiopathology
  • Promoter Regions, Genetic / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Stress, Psychological / physiopathology

Substances

  • Insulin
  • Glucagon-Like Peptide 1
  • Corticotropin-Releasing Hormone
  • Exenatide
  • Glucose